ICON plc to Present at the Jefferies London Healthcare Conference
ICON plc (NASDAQ: ICLR), a leading healthcare intelligence and clinical research organization, has announced its participation in the upcoming Jefferies London Healthcare Conference. Dr. Steve Cutler (CEO) and Nigel Clerkin (CFO) will deliver a presentation on Thursday, November 21, 2024 at 8:00am GMT. Updates regarding the event and webcast links will be available in the Investor section of ICON's website under 'Events'.
ICON plc (NASDAQ: ICLR), una delle principali organizzazioni di ricerca clinica e intelligenza sanitaria, ha annunciato la sua partecipazione alla prossima Jefferies London Healthcare Conference. Il Dr. Steve Cutler (CEO) e Nigel Clerkin (CFO) presenteranno una relazione giovedì 21 novembre 2024 alle 8:00 GMT. Aggiornamenti riguardanti l'evento e i link per la trasmissione in diretta saranno disponibili nella sezione Investitori del sito web di ICON sotto 'Eventi'.
ICON plc (NASDAQ: ICLR), una organización líder en inteligencia en salud e investigación clínica, ha anunciado su participación en la próxima Jefferies London Healthcare Conference. El Dr. Steve Cutler (CEO) y Nigel Clerkin (CFO) ofrecerán una presentación el jueves 21 de noviembre de 2024 a las 8:00am GMT. Las actualizaciones sobre el evento y los enlaces al streaming estarán disponibles en la sección de Inversores del sitio web de ICON bajo 'Eventos'.
ICON plc (NASDAQ: ICLR)은 주도적인 의료 정보 및 임상 연구 조직으로서 다가오는 제퍼리 런던 헬스케어 컨퍼런스에 참여할 것임을 발표했습니다. 스티브 커틀러 박사 (CEO)와 나이절 클레르킨 (CFO)이 2024년 11월 21일 목요일 오전 8시 GMT에 발표를 진행할 것입니다. 행사에 대한 업데이트와 웹캐스트 링크는 ICON 웹사이트의 투자자 섹션의 '이벤트'에서 확인할 수 있습니다.
ICON plc (NASDAQ: ICLR), une organisation leader en matière d'intelligence sanitaire et de recherche clinique, a annoncé sa participation à la prochaine Jefferies London Healthcare Conference. Dr. Steve Cutler (PDG) et Nigel Clerkin (DGF) présenteront une communication jeudi 21 novembre 2024 à 8h00 GMT. Des mises à jour concernant l'événement et les liens pour le webcast seront disponibles dans la section Investisseurs du site web d'ICON sous 'Événements'.
ICON plc (NASDAQ: ICLR), eine führende Organisation für Gesundheitsintelligenz und klinische Forschung, hat seine Teilnahme an der bevorstehenden Jefferies London Healthcare Conference angekündigt. Dr. Steve Cutler (CEO) und Nigel Clerkin (CFO) werden am Donnerstag, den 21. November 2024 um 8:00 Uhr GMT eine Präsentation halten. Updates zur Veranstaltung und Links zur Webübertragung sind im Investorenbereich der ICON-Website unter 'Veranstaltungen' verfügbar.
- None.
- None.
Any changes to this event and links to the live webcast will be posted on the Investor section of our website under “Events”.
About ICON plc
ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations. We develop new innovations, drive emerging therapies forward and improve patient lives. With headquarters in
This press release contains forward-looking statements, including statements about our financial guidance. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as other economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are available on the SEC's website at http://www.sec.gov.
ICON/ICLR-G
View source version on businesswire.com: https://www.businesswire.com/news/home/20241112525366/en/
Kate Haven Vice President Investor Relations +1888 381 7923
Source: ICON plc
FAQ
When will ICON plc (ICLR) present at the Jefferies London Healthcare Conference 2024?
Who will represent ICON plc (ICLR) at the Jefferies London Healthcare Conference 2024?
Where can investors find the webcast link for ICON's (ICLR) Jefferies Conference presentation?
